Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

被引：6
|
作者：
VanderLaan, Paul A. [1 ,2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
CANCER CYTOPATHOLOGY | 2019年 / 127卷 / 05期
关键词：
ALK; biomarker testing; EGFR; guideline; immunocytochemistry; immunohistochemistry; non-small cell lung cancer; NTRK; PD-L1; ROS1; IMMUNOHISTOCHEMISTRY;
D O I：
10.1002/cncy.22138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278 / 280
页数：3
相关论文
共 50 条
  • [1] Predictive immunocytochemistry in non-small cell lung carcinoma
    Brcic, Luka
    Prince, Spasenija Savic
    PATHOLOGE, 2022, 43 (03): : 222 - 228
  • [2] Predictive immunocytochemistry in non-small cell lung carcinoma
    Brcic, Luka
    Prince, Spasenija Savic
    PATHOLOGIE, 2022, 43 (03): : 222 - 228
  • [3] Predictive Biomarker Testing for Programmed Cell Death 1 Inhibition in Non-Small Cell Lung Cancer
    Sheffield, Brandon S.
    Geller, Georgia
    Pleasance, Erin
    Zachara-Szczakowski, Susanna
    Milne, Katy
    Kalloger, Steve E.
    Zhao, Eric
    Bidnur, Samir
    Jones, Martin
    Nelson, Brad H.
    Yip, Stephen
    Marra, Marco A.
    Laskin, Janessa
    Ho, Cheryl
    Ionescu, Diana
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
  • [4] Predictive biomarker testing rates in patients with metastatic non-small cell lung cancer in The Netherlands
    de Jager, V.
    Garcia, B. N. Cajiao
    Kuijpers, C. C.
    de Bock, G. H.
    Maas, W. J.
    Timens, W.
    van Kempen, L. C.
    van der Wekken, A. J.
    Schuuring, E.
    Willems, S. M.
    VIRCHOWS ARCHIV, 2024, 485 : S139 - S140
  • [5] Predictive biomarker analysis of non-small cell lung cancer patients
    Sakellariou, S.
    Karatrasoglou, E. A.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Zougros, A.
    Rouppou, E.
    Stamopoulos, K.
    Lazaris, A. C.
    Korkolopoulou, P.
    Saetta, A.
    VIRCHOWS ARCHIV, 2019, 475 : S105 - S105
  • [6] Current and future trends in non-small cell lung cancer biomarker testing: The American experience
    VanderLaan, Paul A.
    Roy-Chowdhuri, Sinchita
    CANCER CYTOPATHOLOGY, 2020, 128 (09) : 629 - 636
  • [7] Immunocytochemistry for predictive biomarker testing in lung cancer cytology
    Jain, Deepali
    Nambirajan, Aruna
    Borczuk, Alain
    Chen, Gang
    Minami, Yuko
    Moreira, Andre L.
    Motoi, Noriko
    Papotti, Mauro
    Rekhtman, Natasha
    Russell, Prudence A.
    Prince, Spasenija Savic
    Yatabe, Yasushi
    Bubendorf, Lukas
    CANCER CYTOPATHOLOGY, 2019, 127 (05) : 325 - 339
  • [8] Non-Small Cell Lung Cancer: Recommendations for Biomarker Testing and Treatment
    Aisner, Dara L.
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 610 - 613
  • [9] Immunotherapy in non-small cell lung cancer: The past, the present, and the future
    Lu, Meng
    Su, Yanjun
    THORACIC CANCER, 2019, 10 (04) : 585 - 586
  • [10] Clinical predictive values of biomarker levels in non-small cell lung cancer
    Wenqing Wei
    Oncology and Translational Medicine, 2017, 3 (06) : 245 - 248
12345